Originally published on: May 22nd 2020
Originally published on www.globalresearch.ca
The COV-19 vaccineis now front page news. Yet the first tests were conducted in mid-March and there was virtually no coverage. The following article by Prof. Michel Chossudovsky
was first published by Global Research on March 17, 2020, following the first tests of a vaccine conducted by Moderna Inc. with human volunteers in Seattle on March 16.
The tendency is towards a Worldwide lockdown spearheaded by fear and media disinformation. Currently, hundreds of millions of people Worldwide are under lockdown.
What is the next step in the evolution of the COV-19 Crisis?
The lead entity for the novel coronavirus vaccine initiative is the Coalition for Epidemic Preparedness Innovations (CEPI) an organization sponsored and financed by the World Economic Forum (WEF) and the Bill and Melinda Gates Foundation.
Note the chronology: The development of the 2019 nCoV vaccine was announced at the Davos World Economic Forum (WEF) a week prior to the official launching by the WHO of a Worldwide Public Health Emergency (January 30) at a time when the number of “confirmed cases” Worldwide (outside China) was 150 (including 6 in the US).
The pandemic was launched by the WHO on March 11. And five days later, barely covered by the media, the first tests involving human volunteers were conducted in Seattle on March 16.
CEPI is seeking a “monopoly” role in the vaccination business the objective of which is a “global vaccine project”, in partnership with a large number of “candidates”. It announced funding for its existing partnership with Inovio and The University of Queensland (Australia). In addition, CEPI confirmed (January 23) its contract with Moderna, Inc. and the U.S. National Institute of Allergy and Infectious Diseases (NIAID) headed by Dr. Anthony Fauci, who has been instrumental in waging the fear and panic campaign across America: “Ten Times Worse than Seasonal Flu”.
According to a report of the WHO pertaining to China’s epidemic (which has currently been resolved):
The most commonly reported symptoms [of COVID-19] included fever, dry cough, and shortness of breath, and most patients (80%) experienced mild illness. Approximately 14% experienced severe disease and 5% were critically ill. Early reports suggest that illness severity is associated with age (>60 years old) and co-morbid disease. (largely basing on WHO’s assessment of COVID-19 in China)
Screenshot The Hill, March 19, 2020
The Central Role of CEPI
CEPI is dealing simultaneously with several pharmaceutical companies. The Moderna- NIAID in all likelihood is slated to implement the COV-19 vaccine in the US.
On January 31st, the day following the WHO’s official launching of the global public health emergency and Trump’s decision to curtail air travel with China, CEPI announced its partnership with CureVac AG, a German-based biopharmaceutical company. A few days later, in early February, CEPI “announced that major vaccine manufacturer GSK would allow its proprietary adjuvants— compounds that boost the effectiveness of vaccines — to be used in the response”. (The pandemic was officially launched on March 11)
There are many “potential vaccines in the pipeline” with “dozens of research groups around the world racing to create a vaccine against COVID-19”.
In turn the EU and the US are currently competing for the vaccine markets on behalf of powerful pharmaceutical conglomerates, with the European Commission “offering up to €80 million in financial support to the CureVac AG” after it was reported that Trump “was attempting to secure exclusive access to a COVID-19 vaccine it is developing”, under the auspices of NIAID headed by Dr. Anthony Fauci.
The October 2019 Coronavirus Event 201 Simulation Exercise
The coronavirus was initially named 2019-nCoV by CEPI and the WHO: exactly the same name as that adopted in the WEF-Gates-John Hopkins Event 201 pertaining to a coronavirus simulation exercise held in Baltimore in mid October 2019.
The Event 201 John Hopkins simulation addressed the development of an effective vaccine in response to millions of cases (in the October 2019 simulation) of the 2019 nCoV. The simulation announced a scenario in which the entire population of the planet would be affected. “During the initial months of the pandemic, the cumulative number of cases [in the simulation] increases exponentially, doubling every week. And as the cases and deaths accumulate, the economic and societal consequences become increasingly severe.”
The scenario ends at the 18-month point, with 65 million deaths. The pandemic is beginning to slow due to the decreasing number of susceptible people. The pandemic will continue at some rate until there is an effective vaccine or until 80-90 % of the global population has been exposed. From that point on, it is likely to be an endemic childhood disease.
The COV-19 Global Vaccination Program
CEPI (on behalf of Gates-WEF, which funded the simulation exercise) is currently playing a key role in a large scale (global?) vaccination program in partnership with biotech companies, Big Pharma, government agencies as well as university laboratories.
The foregoing statement by CEPI was made nearly two months prior to the official declaration of a pandemic on March 11.
“We’re having conversations with a broad array of potential partners”. And critical to those conversations is: What’s the plan to make very large quantities of vaccine within a time frame that is potentially relevant to what people seem to be increasingly certain will be a pandemic, if it isn’t already there? …” [Richard Hatchett, CEPI CEO in interview with stat.news.com].
The underlying focus is to develop a global vaccine.
And part of that was doing a global survey of manufacturing capacity to think about where we wanted to plant the manufacturing of any successful products we were able to bring forward.
Of significance, Hackett confirmed that the project to develop a vaccine commenced not only prior to the discovery and identification of the coronavirus (January 2020) but several months prior to the October 2019 simulation exercise.
“We did that in the last year or so. We are using the information that we have collected and have that team now thinking about opportunities for scaling vaccines of various different types. That is a work in progress. For some of the technologies the tech transfer [to a manufacturer] may be something that could be done in a time frame that was pertinent to the epidemic, potentially.
I think it is going to be really important to engage those folks who have access to really substantial production capacity. And having the big producers at the table — because of their depth, because of their experience, because of their internal resources — would be very, very important.
The candidate vaccines will be very, very quick. Dr. Anthony Fauci, director of NIAID [who has been spreading panic on network TV], is out in public as saying he thinks the clinical trial for the Moderna vaccine may be as early as the spring. (emphasis added)
What is unfolding in real life is in some regards similar to the October 2019 simulation exercise at John Hopkins. The scenario is how to produce millions of vaccine shots on the presumption that the pandemic will spread.
The CEPI sponsored vaccine conglomerates had already planned their investments well in advance of the global Worldwide health emergency (January 20th).
I [Hackett] think part of the general strategy is to have a large number of candidates. [and] you want to have enough candidates that at least some of them are moving rapidly through the process.
And then for each candidate, you need to ask yourself the question: How do you produce that? … [And] how are you going to get to that point with production at a scale that is meaningful in the context of a disease that is going to infect the whole of society? (Interview conducted by Helen Branswell, statsnews, February 3, 2020)
Moderna Inc based in Seattle is one of several candidates involved and supported by CEPI.
Moderna announced on February 24th the development of “an experimental mRNA COVID-19 vaccine, known as mRNA-1273″. “The initial batch of the vaccine has already been shipped to U.S. government researchers from the National Institute of Allergy and Infectious Diseases (NIAID)” headed by Dr. Antony Fauci.
While Moderna Inc initially stated that the first clinical trials would commence in late April, tests involving human volunteers started in mid-March in Seattle: (bear in mind the pandemic was officially launched on March 11).
Researchers in Seattle gave the first shot to the first person in a test of an experimental coronavirus vaccine Monday — leading off a worldwide hunt for protection even as the pandemic surges.
Some of the study’s carefully chosen healthy volunteers, ages 18 to 55, will get higher dosages than others to test how strong the inoculations should be. Scientists will check for any side effects and draw blood samples to test if the vaccine is revving up the immune system, looking for encouraging clues like the NIH earlier found in vaccinated mice.
“We don’t know whether this vaccine will induce an immune response, or whether it will be safe. That’s why we’re doing a trial,” Jackson stressed. “It’s not at the stage where it would be possible or prudent to give it to the general population.” (FOX news local)
CEPI’s nCoV-2019 Global Vaccine and the ID2020 Digital Identity Platform
While CEPI announced the launching of a global vaccine at the Davos World Economic Forum, another important and related endeavor was underway. It’s called the ID2020 Agenda, which, according to Peter Koenig constitutes “an electronic ID program that uses generalized vaccination as a platform for digital identity”.
“The program harnesses existing birth registration and vaccination operations to provide newborns with a portable and persistent biometrically-linked digital identity”. (Peter Koenig, March 2020)
The Founding Partners of ID2020 are Microsoft, the Rockefeller Foundation and the Global Alliance for Vaccines and Immunization (GAVI) among others.
It is worth noting the timeline: The ID2020 Alliance held their Summit in New York, entitled “Rising to the Good ID Challenge”, on September 19,2020, exactly one month prior to nCov-2019 simulation exercise entitled Event 201 at John Hopkins in Baltimore.
Is it just a coincidence that ID2020 is being rolled out at the onset of what the WHO calls a Pandemic? – Or is a pandemic needed to ‘roll out’ the multiple devastating programs of ID2020? (Peter Koenig, March 2020)
ID2020 is part of a “World Governance” project which, if applied, would roll out the contours of what some analysts have described as a Global Police State encompassing through vaccination the personal details of several billion people Worldwide.
In the Wake of the Lockdown
The fear campaign will continue in the wake of the lockdown. Will the hardships of the economic and social crisis encourage people to get vaccinated?
To implement the Global Vaccine, the propaganda campaign must continue. The Truth must be suppressed. These are their “guidelines”, which must be confronted and challenged.
The main actors including CEPI will require the firm endorsement of the WHO (which they control), a green light from the scientific community as well bold statements by corrupt politicians.
Moreover, they will have to suppress information and analysis on the features of the virus, how it can easily be cured (without a vaccine), which is currently the object of debate by virologists and physicians in several countries including the US. In recent developments, hydroxychloroquine is being used to treat patients in both Europe and North America. Big Pharma is intent upon suppressing evidence on how COVID-19 can be cured. The media is complicit. It is not informing the public.
Remember the 2009 H1N1 swine flu pandemic when Obama’s Council of Advisors on Science and Technology compared the H1N1 pandemic to the 1918 Spanish flu pandemic while reassuring the public that the latter was more deadly. (CBC: Get swine flu vaccine ready: U.S. advisers)
Based on incomplete and scanty data, the WHO Director General predicted with authority that: “as many as 2 billion people could become infected over the next two years — nearly one-third of the world population.” (World Health Organization as reported by the Western media, July 2009).
It was a multibillion bonanza for Big Pharma supported by the WHO’s Director-General Margaret Chan.
In a subsequent statement she confirmed that:
“Vaccine makers could produce 4.9 billion pandemic flu shots per year in the best-case scenario”, Margaret Chan, Director-General, World Health Organization (WHO), quoted by Reuters, 21 July 2009).
“Swine flu could strike up to 40 percent of Americans over the next two years and as many as several hundred thousand could die if a vaccine campaign and other measures aren’t successful.” (Official Statement of Obama Administration, Associated Press, 24 July 2009).
There was no pandemic affecting 2 billion people… Millions of doses of swine flu vaccine had been ordered by national governments from Big Pharma. Millions of vaccine doses were subsequently destroyed: a financial bonanza for Big Pharma, an expenditure crisis for national governments.
There was no investigation into who was behind this multibillion fraud. Several critics said that the H1N1 Pandemic was “Fake”
The Parliamentary Assembly of the Council of Europe (PACE), a human rights watchdog, is publicly investigating the WHO’s motives in declaring a pandemic. Indeed, the chairman of its influential health committee, epidemiologist Wolfgang Wodarg, has declared that the “false pandemic” is “one of the greatest medicine scandals of the century.” (Michael Fomento, Forbes, February 10, 2010)
Michael Fomento concludes:
Even within the agency, the director of the WHO Collaborating Center for Epidemiology in Munster, Germany, Dr. Ulrich Kiel, has essentially labeled the pandemic a hoax. “We are witnessing a gigantic misallocation of resources [$18 billion so far] in terms of public health,” he said.
They’re right. This wasn’t merely overcautiousness or simple misjudgment. The pandemic declaration and all the Klaxon-ringing since reflect sheer dishonesty motivated not by medical concerns but political ones.
Unquestionably, swine flu has proved to be vastly milder than ordinary seasonal flu. It kills at a third to a tenth the rate, according to U.S. Centers for Disease Control and Prevention estimates. Data from other countries like France and Japan indicate it’s far tamer than that.
COVID-19 is Déjà Vu. Lets not be taken in again.
We are currently in a Lockdown, We have time to reflect. There are important lessons to be learnt from the 2009 H1N1 Pandemic
The COVID-19 pandemic is far more serious and diabolical than the 2009 H1N1. The COV-19 pandemic has provided a pretext and a justification for destabilizing the economies of entire countries, impoverishing large sectors of the World population. Unprecedented in modern history.
And it is important that we act cohesively and in solidarity with those who are victims of this crisis. People’s lives are in a freefall and their purchasing power has been destroyed. What kind of twisted social structure awaits us in the wake of the lockdown?
Can we trust the World Health Organization (WHO) and the powerful economic interest groups behind it. The answer is obvious.
Can we trust the main actors behind the multibillion dollar global vaccination project?
Can we trust the Western media which has led the fear campaign? Disinformation sustains the lies and fabrications. Can we trust our “corrupt” governments? Our national economy has been devastated.
This is an act of “economic warfare” against humanity.
The Centre for Research on Globalization (CRG) is an independent research and media organization based in Montreal. The CRG is a registered non-profit organization in the province of Quebec, Canada.
In addition to the Global Research websites, the Centre is involved in book publishing, support to humanitarian projects as well as educational outreach activities including the organization of public conferences and lectures. The Centre also acts as a think tank on crucial economic and geopolitical issues.
© [Article Date] GreenMedInfo LLC. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Sign up for the newsletter here https://www.greenmedinfo.com/greenmed/newsletter.
Originally published on: May 22nd 2020